{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:59:20Z","timestamp":1790798360357,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1314100"],"award-info":[{"award-number":["2018YFC1314100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48843-2","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:06:28Z","timestamp":1776776788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of mulberry twig alkaloids and canagliflozin in inadequately controlled type 2 diabetes: a randomized controlled study based on flash glucose monitoring"],"prefix":"10.1038","volume":"16","author":[{"given":"Huiqin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShanShan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rengna","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baowen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocen","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"48843_CR1","doi-asserted-by":"publisher","first-page":"108630","DOI":"10.1016\/j.diabres.2020.108630","volume":"172","author":"P Aschner","year":"2021","unstructured":"Aschner, P. et al. The International Diabetes Federation\u2019s guide for diabetes epidemiological studies. Diabetes Res. Clin. Pract. 172, 108630 (2021).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"24","key":"48843_CR2","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1001\/jama.2021.22208","volume":"326","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Prevalence and treatment of diabetes in China, 2013\u20132018. JAMA 326(24), 2498\u20132506 (2021).","journal-title":"JAMA"},{"key":"48843_CR3","doi-asserted-by":"publisher","first-page":"m997","DOI":"10.1136\/bmj.m997","volume":"369","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: National cross sectional study. BMJ 369, m997 (2020).","journal-title":"BMJ"},{"key":"48843_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jep.2019.02.024","volume":"235","author":"CI Chukwuma","year":"2019","unstructured":"Chukwuma, C. I. et al. Medicinal plants with concomitant anti-diabetic and anti-hypertensive effects as potential sources of dual acting therapies against diabetes and hypertension: A review. J. Ethnopharmacol. 235, 329\u2013360 (2019).","journal-title":"J. Ethnopharmacol."},{"key":"48843_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118354","volume":"332","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD. J. Ethnopharmacol. 332, 118354 (2024).","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"48843_CR6","first-page":"17","volume":"14","author":"EW Chan","year":"2016","unstructured":"Chan, E. W., Lye, P. Y. & Wong, S. K. Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin. J. Nat. Med. 14(1), 17\u201330 (2016).","journal-title":"Chin. J. Nat. Med."},{"key":"48843_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jpba.2015.02.019","volume":"109","author":"S Yang","year":"2015","unstructured":"Yang, S. et al. Simultaneous quantification of three active alkaloids from a traditional Chinese medicine Ramulus Mori (Sangzhi) in rat plasma using liquid chromatography-tandem mass spectrometry. J. Pharm. Biomed. Anal. 109, 177\u2013183 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"48843_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.841981","volume":"13","author":"L Lei","year":"2022","unstructured":"Lei, L. et al. Morus alba L. (Sangzhi) alkaloids promote insulin secretion, restore diabetic beta-cell function by preventing dedifferentiation and apoptosis. Front. Pharmacol. 13, 841981 (2022).","journal-title":"Front. Pharmacol."},{"key":"48843_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11050905","author":"YM Chen","year":"2022","unstructured":"Chen, Y. M. et al. Ramulus mori (Sangzhi) alkaloids alleviate high-fat diet-induced obesity and nonalcoholic fatty liver disease in mice. Antioxidants\u00a0(Basel). 11(5), 905 (2022).\u00a0","journal-title":"Antioxidants"},{"key":"48843_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.642400","volume":"12","author":"Q Liu","year":"2021","unstructured":"Liu, Q. et al. Ramulus Mori (Sangzhi) alkaloids (SZ-A) ameliorate glucose metabolism accompanied by the modulation of gut microbiota and ileal inflammatory damage in type 2 diabetic KKAy mice. Front. Pharmacol. 12, 642400 (2021).","journal-title":"Front. Pharmacol."},{"key":"48843_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114483","volume":"280","author":"H Cao","year":"2021","unstructured":"Cao, H. et al. Morus alba L. (Sangzhi) alkaloids (SZ-A) exert anti-inflammatory effects via regulation of MAPK signaling in macrophages. J. Ethnopharmacol. 280, 114483 (2021).","journal-title":"J. Ethnopharmacol."},{"key":"48843_CR12","doi-asserted-by":"publisher","first-page":"155526","DOI":"10.1016\/j.phymed.2024.155526","volume":"128","author":"D Peng","year":"2024","unstructured":"Peng, D. et al. Morus alba L. (Sangzhi) alkaloids mitigate atherosclerosis by regulating M1\/M2 macrophage polarization. Phytomedicine 128, 155526 (2024).","journal-title":"Phytomedicine"},{"issue":"6","key":"48843_CR13","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.2337\/dc20-2109","volume":"44","author":"L Qu","year":"2021","unstructured":"Qu, L. et al. Efficacy and safety of mulberry twig alkaloids tablet for the treatment of type 2 diabetes: A multicenter, randomized, double-blind, double-dummy, and parallel controlled clinical trial. Diabetes Care 44(6), 1324\u20131333 (2021).","journal-title":"Diabetes Care"},{"issue":"4","key":"48843_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s11655-021-2885-9","volume":"28","author":"L Qu","year":"2022","unstructured":"Qu, L. et al. Efficacy and safety of mulberry twig alkaloids tablet for treatment of type 2 diabetes: A randomized, double-blind, placebo-controlled multicenter clinical study. Chin. J. Integr. Med. 28(4), 304\u2013311 (2022).","journal-title":"Chin. J. Integr. Med."},{"issue":"5","key":"48843_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00125-024-06099-3","volume":"67","author":"P Cardoso","year":"2024","unstructured":"Cardoso, P. et al. Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Diabetologia 67 (5), 822\u2013836 (2024).","journal-title":"Diabetologia"},{"key":"48843_CR16","doi-asserted-by":"crossref","unstructured":"Neumiller, J. J., White, J. R. Jr. & Campbell, R. K. Sodium-glucose co-transport inhibitors: Progress and therapeutic potential in type 2 diabetes mellitus. Drugs 70(4), 377\u2013385 (2010).","DOI":"10.2165\/11318680-000000000-00000"},{"issue":"6","key":"48843_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2337\/dc11-1926","volume":"35","author":"J Rosenstock","year":"2012","unstructured":"Rosenstock, J. et al. Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes. Diabetes Care. 35 (6), 1232\u20131238 (2012).","journal-title":"Diabetes Care"},{"key":"48843_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12134248","author":"JJ Gorgojo-Martinez","year":"2023","unstructured":"Gorgojo-Martinez, J. J. et al. Effectiveness and tolerability of the intensification of canagliflozin dose from 100 mg to 300 mg daily in patients with type 2 diabetes in real life: The INTENSIFY study. J. Clin. Med. 12(13), 4248\u00a0(2023).","journal-title":"J. Clin. Med."},{"issue":"1","key":"48843_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2213-8587(19)30385-7","volume":"8","author":"J Furler","year":"2020","unstructured":"Furler, J. et al. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): A pragmatic, open-label, 12-month, randomised controlled trial. Lancet Diabetes Endocrinol 8(1), 17\u201326 (2020).","journal-title":"Lancet Diabetes Endocrinol"},{"key":"48843_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110568","volume":"197","author":"J Zhu","year":"2023","unstructured":"Zhu, J. et al. Clinical expert consensus on the assessment and protection of pancreatic islet beta-cell function in type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 197, 110568 (2023).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"48843_CR21","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1365-2265.2011.04205.x","volume":"76","author":"C Wang","year":"2012","unstructured":"Wang, C. et al. Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin. Endocrinol. (Oxf.) 76(6), 810\u2013815 (2012).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"48843_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/00325481.2020.1851946","volume":"133","author":"TW Martens","year":"2021","unstructured":"Martens, T. W. et al. Making sense of glucose metrics in diabetes: Linkage between postprandial glucose (PPG), time in range (TIR) & hemoglobin A1c (A1C). Postgrad. Med. 133(3), 253\u2013264 (2021).","journal-title":"Postgrad. Med."},{"issue":"2","key":"48843_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2337\/dc20-1862","volume":"44","author":"J Lu","year":"2021","unstructured":"Lu, J. et al. Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: A prospective cohort study. Diabetes Care 44(2), 549\u2013555 (2021).","journal-title":"Diabetes Care"},{"issue":"11","key":"48843_CR24","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.2337\/dc18-1131","volume":"41","author":"J Lu","year":"2018","unstructured":"Lu, J. et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes. Diabetes Care 41(11), 2370\u20132376 (2018).","journal-title":"Diabetes Care"},{"issue":"4","key":"48843_CR25","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/1932296818822496","volume":"13","author":"RW Beck","year":"2019","unstructured":"Beck, R. W. et al. The relationships between time in range, hyperglycemia metrics, and HbA1c. J. Diabetes Sci. Technol. 13(4), 614\u2013626 (2019).","journal-title":"J. Diabetes Sci. Technol."},{"key":"48843_CR26","doi-asserted-by":"crossref","unstructured":"Battelino, T. et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the International Consensus on Time in Range. Diabetes Care 42(8), 1593\u20131603 (2019).","DOI":"10.2337\/dci19-0028"},{"issue":"3","key":"48843_CR27","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.2337\/dc20-2798","volume":"44","author":"JS Rana","year":"2021","unstructured":"Rana, J. S., Moffet, H. H., Liu, J. Y. & Karter, A. J. Severe hypoglycemia and risk of atherosclerotic cardiovascular disease in patients with diabetes. Diabetes Care 44(3), e40\u2013e41 (2021).","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"48843_CR28","first-page":"S145","volume":"47","author":"Committee, A. D. A. P. P.","year":"2024","unstructured":"Committee, A. D. A. P. P. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: Standards of care in diabetes-2024. Diabetes Care 47(Suppl 1), S145-s157 (2024).","journal-title":"Diabetes Care"},{"key":"48843_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/nu14235050","author":"QW Sun","year":"2022","unstructured":"Sun, Q. W. et al. Ramulus mori (Sangzhi) alkaloids ameliorate obesity-linked adipose tissue metabolism and inflammation in mice. Nutrients\u00a014(23), 5050 (2022).","journal-title":"Nutrients"},{"key":"48843_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/nu15183914","author":"F Wang","year":"2023","unstructured":"Wang, F., Xu, S. J., Ye, F., Zhang, B. & Sun, X. B. Integration of transcriptomics and lipidomics profiling to reveal the therapeutic mechanism underlying Ramulus mori (Sangzhi) alkaloids for the treatment of liver lipid metabolic disturbance in high-fat-diet\/streptozotocin-induced diabetic mice. Nutrients\u00a015(18), 3914 (2023).","journal-title":"Nutrients"},{"key":"48843_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1166635","volume":"14","author":"D Liu","year":"2023","unstructured":"Liu, D. et al. Ramulus mori (Sangzhi) alkaloids regulates gut microbiota disorder and its metabolism profiles in obese mice induced by a high-fat diet. Front. Pharmacol. 14, 1166635 (2023).","journal-title":"Front. Pharmacol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48843-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48843-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48843-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:02:57Z","timestamp":1781528577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48843-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48843"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48843-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8391022\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18502"}}